Glen Harbor Capital Management’s Health Catalyst HCAT Stock Holding History

Glen Harbor Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$815K	Buy	+25,762	New	+$1.01M	0.02%	525

Other funds holding HCAT

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Glen Harbor Capital Management's HCAT Position: Q3 2019 in Review

Glen Harbor Capital Management opened a new position in Health Catalyst (HCAT) in Q3 2019: 25,762 shares worth $815K. The stake represents 0.02% of the portfolio and ranks #525 among its holdings.

86 funds tracked by Wall St. Rank hold HCAT as of Q3 2019.

Glen Harbor Capital Management held 25,762 shares of Health Catalyst worth $815K as of Q3 2019.
Health Catalyst was a new Glen Harbor Capital Management position in Q3 2019.
Health Catalyst made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #525 holding.
86 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.